Skip to main content

Publications

Confronting the growing epidemic of silicosis and tuberculosis among small-scale miners

Editorial

An estimated 49·5 million small-scale miners worldwide are exposed to high concentrations of silica during their work. The substantial morbidity and mortality of silicosis and tuberculosis among workers exposed to such intensities have been documented. This Viewpoint raises concern at the failure to respond to a growing epidemic of lung disease (predominantly silicosis and tuberculosis) among small-scale miners.

Assessment of cancer biomarkers in the Grenfell firefighter cohort study

Article
Using next-generation sequencing and a panel that detects pathogenic DNA variants linked to various cancers, we analysed a subset of 261 firefighters. Our findings revealed that 11 firefighters carried pathogenic DNA variants associated with cancer, but we found no association between fire smoke exposure and the presence of these variants.

Small airways obstruction and mortality: findings from the UK Biobank

Article

Background

Small airways obstruction (SAO) is common in general populations. It has been associated with respiratory symptoms, cardiometabolic diseases, and progression to COPD over time. Whether SAO predicts mortality is largely unknown.

Research Question

Is spirometry-defined SAO associated with increased mortality?

Methods

Occupational exposure to particulate matter and staff sickness absence on the London underground

Article

The London Underground (LU) employs over 19,000 staff, some of whom are exposed to elevated concentrations of particulate matter (PM) within the network. This study quantified the occupational exposure of LU staff to subway PM and investigated the possible association with sickness absence (SA).

A job exposure matrix to quantify subway PM2.5 staff exposure was developed by undertaking measurement campaigns across the LU network. The association between exposure and SA was evaluated using zero-inflated mixed-effects negative binomial models.

Scoping review of exposure questionnaires and surveys in interstitial lung disease

Article

Background Many interstitial lung diseases (ILDs) have clear causal relationships with environmental and occupational exposures. Exposure identification can assist with diagnosis, understanding disease pathogenesis, prognostication and prevention of disease progression and occurrence in others at risk. Despite the importance of exposure identification in ILD, there is no standardised assessment approach. Many questionnaires are in clinical and research use, yet their utility, applicability, relevance and performance characteristics are unknown.

Artificial stone silicosis: A UK case series

Article

Silicosis due to artificial stone (AS) has emerged over the last decade as an increasing global issue. We report the first eight UK cases. All were men; median age was 34 years (range 27–56) and median stone dust exposure was 12.5 years (range 4–40) but in 4 cases was 4–8 years. One is deceased; two were referred for lung transplant assessment. All cases were dry cutting and polishing AS worktops with inadequate safety measures. Clinical features of silicosis can closely mimic sarcoidosis.

Relationship between cumulative silica exposure and silicosis: a systematic review and dose-response meta-analysis

Article
Silicosis, a chronic respiratory disease caused by crystalline silica exposure, is a persistent global lung health issue. No systematic review of the relationship between cumulative respirable crystalline silica (RCS) exposure and silicosis exists. UK exposure limits are currently under review. We therefore performed a systematic review and dose-response meta-analysis of this relationship.

A call to invest in post-TB lung disease to halt TB transmission in communities

Article

Dear Editor We undertook an evaluation of former TB patients for pulmonary rehabilitation. Our diagnostic evaluation aimed to implement clinical standards for post-TB lung disease (PTLD) using operational research. 1 Nightingale et al. also issued a clinical statement, addressing diverse post-TB morbidities such as social, economic, neurological, cardiovascular, PTLD and psychiatric impairments. 2 In low-and middle-income African countries (such as Sudan, Ethiopia and Kenya), only 4 in 10 clinicians can diagnose PTLD, contributing to an underestimation of its burden.